Market Closed -
Nasdaq Stockholm
11:29:49 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.963
SEK
|
+4.50%
|
|
+6.35%
|
-44.01%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3,179
|
5,928
|
5,327
|
6,084
|
1,233
|
586.3
|
586.3
|
-
|
Enterprise Value (EV)
1 |
2,639
|
5,394
|
4,973
|
6,002
|
1,277
|
1,020
|
537.3
|
454.3
|
P/E ratio
|
-5.04
x
|
-472
x
|
-15.8
x
|
-
|
-1.53
x
|
-
|
-96.3
x
|
10.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
41.5%
|
Capitalization / Revenue
|
2.07
x
|
4.06
x
|
4.24
x
|
4.49
x
|
1.43
x
|
1.45
x
|
0.54
x
|
0.44
x
|
EV / Revenue
|
2.07
x
|
4.06
x
|
4.24
x
|
4.49
x
|
1.43
x
|
1.45
x
|
0.54
x
|
0.44
x
|
EV / EBITDA
|
-6.29
x
|
-
|
-
|
-
|
-10.6
x
|
-4.21
x
|
10.1
x
|
4.81
x
|
EV / FCF
|
16,759,284
x
|
-
|
-
|
-
|
-2,811,651
x
|
-
|
17,244,258
x
|
5,863,047
x
|
FCF Yield
|
0%
|
-
|
-
|
-
|
-0%
|
-
|
0%
|
0%
|
Price to Book
|
1.79
x
|
3.29
x
|
4.44
x
|
5.93
x
|
1.42
x
|
0.6
x
|
0.88
x
|
0.8
x
|
Nbr of stocks (in thousands)
|
313,968
|
313,968
|
306,000
|
294,200
|
420,693
|
608,832
|
608,832
|
-
|
Reference price
2 |
10.13
|
18.88
|
17.41
|
20.68
|
2.932
|
0.9630
|
0.9630
|
0.9630
|
Announcement Date
|
2/15/19
|
2/13/20
|
2/16/21
|
1/28/22
|
1/26/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,535
|
1,459
|
1,256
|
1,356
|
861.8
|
705.4
|
1,085
|
1,329
|
EBITDA
1 |
-505.2
|
-
|
-
|
-
|
-116
|
-242.2
|
58
|
122
|
EBIT
1 |
-771.6
|
-14.4
|
-
|
-
|
-631
|
-320.4
|
-6
|
73
|
Operating Margin
|
-50.26%
|
-0.99%
|
-
|
-
|
-73.22%
|
-45.42%
|
-0.55%
|
5.49%
|
Earnings before Tax (EBT)
|
-796.7
|
-17.4
|
-
|
-
|
-652.2
|
-
|
-11
|
68
|
Net income
|
-630.7
|
-13.6
|
-340.8
|
0.1
|
-586
|
-
|
-9
|
53
|
Net margin
|
-41.09%
|
-0.93%
|
-27.14%
|
0.01%
|
-68%
|
-
|
-0.83%
|
3.99%
|
EPS
|
-2.010
|
-0.0400
|
-1.100
|
-
|
-1.920
|
-
|
-0.0100
|
0.0900
|
Free Cash Flow
|
189.7
|
-
|
-
|
-
|
-438.7
|
-
|
34
|
100
|
FCF margin
|
12.36%
|
-
|
-
|
-
|
-50.91%
|
-
|
3.13%
|
7.52%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
58.62%
|
81.97%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
188.68%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.4000
|
Announcement Date
|
2/15/19
|
2/13/20
|
2/16/21
|
1/28/22
|
1/26/23
|
4/25/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
43.2
|
-
|
-
|
-
|
Net Cash position
|
541
|
534
|
354
|
81.7
|
-
|
-
|
49
|
132
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.3724
x
|
-
|
-
|
-
|
Free Cash Flow
|
190
|
-
|
-
|
-
|
-439
|
-
|
34
|
100
|
ROE (net income / shareholders' equity)
|
-27%
|
-0.76%
|
-1.2%
|
0.01%
|
-
|
-
|
-
|
7.5%
|
ROA (Net income/ Total Assets)
|
-26.2%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
2,406
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
5.660
|
5.730
|
3.920
|
3.490
|
2.060
|
1.600
|
1.100
|
1.200
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
84.9
|
94.8
|
119
|
91
|
-
|
-
|
4
|
5
|
Capex / Sales
|
5.53%
|
6.5%
|
9.48%
|
6.71%
|
-
|
-
|
0.37%
|
0.38%
|
Announcement Date
|
2/15/19
|
2/13/20
|
2/16/21
|
1/28/22
|
1/26/23
|
4/25/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -44.01% | 53.47M | | -25.52% | 1.55B | | +186.73% | 161M | | +14.63% | 120M |
Biometric Products
|